Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever.
Adekunle Babajide RowaiyeEzinne Janefrances NwonuTitilayo Mercy AsalaAmoge Chidinma OguDoofan BurChimaobi ChukwuAngus Nnamdi OliTarimoboere AgbalalahPublished in: Clinical and experimental vaccine research (2022)
The VC shows good promise in the prevention of Lassa fever but further tests are required to validate its safety and efficacy.